Profile
Edward P.
Owens is currently a Director at Stealth BioTherapeutics Corp.
and Stealth BioTherapeutics, Inc. He previously served as an Independent Director at Ironwood Pharmaceuticals, Inc. and Escape Bio, Inc. He was also a Senior Vice President at Wellington Management Co. LLP and a Portfolio Manager at Vanguard Health Care Fund.
Owens has also served as a Trustee at The Marine Biological Laboratory.
He received his undergraduate degree from the University of Virginia and an MBA from Harvard Business School.
Edward Owens active positions
| Companies | Position | Start |
|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Director/Board Member | 2018-06-21 |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Director/Board Member | 2017-04-30 |
Former positions of Edward Owens
| Companies | Position | End |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Director/Board Member | 2022-05-31 |
Wellington Management Co. LLP
Wellington Management Co. LLP Investment ManagersFinance WMC relies on their extensive independent research and includes portfolio management styles and approaches in equities, fixed income securities, currencies and commodities, as well as asset allocation across these categories. The firm has several different disciplines when approaching research and these include asset allocation analysts, currency analysts, data scientists, factor analysts, fixed income credit analysts, fixed income market analysts, global industry analysts and research associates, macro-analysts, quantitative analysts and technical analysts. | Analyst-Equity | 2013-02-27 |
Vanguard Health Care Fund
Vanguard Health Care Fund Investment Trusts/Mutual FundsMiscellaneous Exists as exchange Traded Fund | Corporate Officer/Principal | 2012-11-30 |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Director/Board Member | - |
The Marine Biological Laboratory
The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services Provides research and educational services | Director/Board Member | - |
Training of Edward Owens
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Wellington Management Co. LLP
Wellington Management Co. LLP Investment ManagersFinance WMC relies on their extensive independent research and includes portfolio management styles and approaches in equities, fixed income securities, currencies and commodities, as well as asset allocation across these categories. The firm has several different disciplines when approaching research and these include asset allocation analysts, currency analysts, data scientists, factor analysts, fixed income credit analysts, fixed income market analysts, global industry analysts and research associates, macro-analysts, quantitative analysts and technical analysts. | Finance |
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Marine Biological Laboratory
The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services Provides research and educational services | Commercial Services |
Vanguard Health Care Fund
Vanguard Health Care Fund Investment Trusts/Mutual FundsMiscellaneous Exists as exchange Traded Fund | Miscellaneous |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Health Technology |
Stealth BioTherapeutics Corp.
Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops investigational drugs for the treatment of diseases involving mitochondrial dysfunction | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Health Technology |
- Stock Market
- Insiders
- Edward Owens
















